Moolec Science S.A.
Moolec Science S.A. (MLEC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mlec · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Moolec Science S.A. (MLEC) measures how much investors pay for each dollar of the company's trailing earnings. MLEC's current PE ratio of N/A is calculated by dividing its stock price of $7.14 by its TTM earnings per share of -$258.69.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Moolec Science S.A.You MLEC | $5M | N/A | — | -$258.69 |
 Dermata Therapeutics, Inc. DRMA | $1M | N/A | — | -$8.16 |
 PMGC Holdings Inc. ELAB | $3M | N/A | — | -$378.74 |
 Galmed Pharmaceuticals Ltd. GLMD | $3M | N/A | — | -$2.39 |
 GT Biopharma, Inc. GTBP | $5M | N/A | — | -$5.14 |
 NewcelX Ltd. NCEL | $1M | N/A | — | -$26.31 |
 NKGen Biotech, Inc. Common Stock NKGN | $8M | N/A | — | -$1.54 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-258.69 | — | |
2024-06-30 FY2024 | — | $-2.85 | — | |
2023-06-30 FY2023 | — | $-22.54 | — | |
2022-06-30 FY2022 | — | $-1.81 | — | |
2021-06-30 FY2021 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Moolec Science S.A. (MLEC) measures how much investors pay for each dollar of the company's trailing earnings. MLEC's current PE ratio of N/A is calculated by dividing its stock price of $7.14 by its TTM earnings per share of -$258.69.
Frequently asked questions
MLEC pe ratio · 6 questionsMLEC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $7.14 and TTM EPS of -$258.69. Data sourced from Financial Modeling Prep via MLEC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Moolec Science S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09